• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Abbott, St. Jude Medical broaden alliance for cardiovascular products

Abbott, St. Jude Medical broaden alliance for cardiovascular products

April 23, 2012
CenterWatch Staff

Global pharmaceutical company Abbott and St Jude Medical of St. Paul, Minn., have collaborated on the Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology, electrophysiology and intravascular imaging, cardiac rhythm management and diagnostic technologies.

This enhanced alliance, which builds upon an existing agreement between the two companies that began in 2008, consists of Abbott's leading coronary and endovascular product portfolios—including the XIENCE family of everolimus eluting coronary stents—and St. Jude's portfolio of electrophysiology, cardiac rhythm management and cardiology technologies—including ablation catheters, pacemakers, implantable cardioverter defibrillators (ICDs), leads, fractional flow reserve (FFR) lesion assessment technology and optical coherence tomography (OCT) imaging products.

Abbott and St. Jude will jointly promote each other's product offerings when developing contract solutions with hospital customers in the U.S., enabling both companies to present a combined comprehensive cardiovascular product portfolio. In addition, a separate distribution agreement between the two companies grants Abbott the rights to distribute St. Jude’s RadiAnalyzer Xpress Measurement and ILUMIEN PCI Optimization System, the only integrated FFR and OCT platform. Combined, FFR and OCT technologies are designed to enable the optimization of percutaneous coronary intervention by assisting physicians in identifying and treating culprit lesions responsible for ischemia.

"Through this arrangement, Abbott becomes the only stent manufacturer to offer physician customers both an advanced imaging technology with FFR to identify vessels for treatment, as well as the stent therapy,” said Lance C. Scott, divisional vice president and general manager, coronary, Abbott.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing